Cite
Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism.
MLA
Paloque, Lucie, et al. “Endoperoxide-Based Compounds: Cross-Resistance with Artemisinins and Selection of a Plasmodium Falciparum Lineage with a K13 Non-Synonymous Polymorphism.” Journal of Antimicrobial Chemotherapy (JAC), vol. 73, no. 2, Feb. 2018, pp. 395–403. EBSCOhost, https://doi.org/10.1093/jac/dkx412.
APA
Paloque, L., Lelièvre, J., Ouji, M., Haddou, T. B., Robert, A., Augereau, J.-M., Meunier, B., Benoit-Vical, F., Witkowski, B., Ménard, D., Ariey, F., & Ben Haddou, T. (2018). Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism. Journal of Antimicrobial Chemotherapy (JAC), 73(2), 395–403. https://doi.org/10.1093/jac/dkx412
Chicago
Paloque, Lucie, Joël Lelièvre, Manel Ouji, Tanila Ben Haddou, Anne Robert, Jean-Michel Augereau, Bernard Meunier, et al. 2018. “Endoperoxide-Based Compounds: Cross-Resistance with Artemisinins and Selection of a Plasmodium Falciparum Lineage with a K13 Non-Synonymous Polymorphism.” Journal of Antimicrobial Chemotherapy (JAC) 73 (2): 395–403. doi:10.1093/jac/dkx412.